6.16
+0.28(+4.76%)
Currency In USD
| Previous Close | 5.88 |
| Open | 5.9 |
| Day High | 6.17 |
| Day Low | 5.81 |
| 52-Week High | 12.38 |
| 52-Week Low | 4.35 |
| Volume | 306,119 |
| Average Volume | 194,141 |
| Market Cap | 382.66M |
| PE | -3.16 |
| EPS | -1.95 |
| Moving Average 50 Days | 6.55 |
| Moving Average 200 Days | 6.79 |
| Change | 0.28 |
If you invested $1000 in Aura Biosciences, Inc. (AURA) since IPO date, it would be worth $416.22 as of September 29, 2025 at a share price of $6.16. Whereas If you bought $1000 worth of Aura Biosciences, Inc. (AURA) shares 3 years ago, it would be worth $357.31 as of September 29, 2025 at a share price of $6.16.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Aura Biosciences to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
GlobeNewswire Inc.
Sep 03, 2025 11:00 AM GMT
BOSTON, Sept. 03, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (NASDAQ: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced that Elisabet de los Pinos
Aura Biosciences Announces Pricing of Public Offering of Common Stock and Warrants
GlobeNewswire Inc.
May 15, 2025 1:32 PM GMT
BOSTON, May 15, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (“Aura”) (Nasdaq: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced the pricing of an u
Aura Biosciences Announces Proposed Public Offering of Common Stock and Warrants
GlobeNewswire Inc.
May 15, 2025 10:10 AM GMT
BOSTON, May 15, 2025 (GLOBE NEWSWIRE) -- Aura Biosciences, Inc. (“Aura”) (Nasdaq: AURA), a clinical-stage biotechnology company developing precision therapies for solid tumors designed to preserve organ function, today announced the launch of an un